17th Annual Symposium on Patient Blood Management, Haemostasis and Thrombosis

Dates & venue

The 17th Annual Symposium on Patient Blood Management, Haemostasis and Thrombosis will be held in Dublin, Ireland, on April 14-15, 2016.

The symposium will take place at the Royal Dublin Society, Ballsbridge, Dublin 4, Republic of Ireland (www.rds.ie).

Invitation from the Chairs

Please click on the link below to read the invitation letter from the chairs of the organising commitee, Jean-François Hardy, NATA Chair, and Jakob Stensballe, Chair of NATA's Scientific Committee

Abstract Submissions

17th Annual NATA Symposium Online Registration

Thursday, April 14, 2016

MORNING

8:45-9:00 Opening Address
Leo Varadkar, Minister for Health, Republic of Ireland (TBC)

NATA Chair’s Welcome Address
Jean-François Hardy, Montreal, QC, Canada

9:00-9:30 Humanitarian aid and medicine—how are we doing in 2016?
Christina Noble, Dublin, Ireland

9:30-9:40 Diagnosis and management of anaemia and iron deficiency
Manuel Muñoz, Málaga, Spain

9:40-9:50 Antithrombotics—when to stop and whom to bridge?
Charles-Marc Samama, Paris, France

9:50-10:00 Bleeding tendency—how to screen and how to monitor?
Beverley J. Hunt, London, UK

10:00-10:10 Preadmission autologous blood donation—should we do it?
Rainer Moog, Cottbus, Germany

10:10-10:30 Discussion

10:30-11:00 Break

11:00-11:10 Restrictive RBC transfusion strategy—but how low?
Jeffrey L. Carson, New Brunswick, NJ, USA

11:10-11:20 Fluid therapy to avoid transfusions
Philippe Van der Linden, Brussels, Belgium

11:20-11:30 Surgical techniques and toys
Toby Richards, London, UK

11:30-11:40 Anaesthetic management—tips and tricks
Rolf Rossaint, Aachen, Germany

11:40-11:50 Viscoelastic haemostatic monitoring for decision support
Jakob Stensballe, Copenhagen, Denmark

11:50-12:00 Cell salvage from start to end
Dafydd Thomas, Swansea, Wales, UK

12:00-12:10 Prohaemostatics—when to use TXA, PCC, fibrinogen or the whole package?
Beverley J. Hunt, London, UK

12:10-12:30 Discussion

Thursday, April 14, 2016

AFTERNOON

14:00-14:10 RBC transfusion strategy—what now?
Jeffrey L. Carson, New Brunswick, NJ, USA

14:10-14:20 Postoperative cell salvage and reinfusion
Dafydd Thomas, Swansea, Wales, UK

14:20-14:30 Anaemia and iron deficiency—any change in strategy?
Elvira Bisbe, Barcelona, Spain

14:30-14:40 Antithrombotics—when to re-start?
Charles-Marc Samama, Paris, France

14:40-14:50 Discussion

14:50-15:00 How to implement perioperative PBM—European/Australian perspective
Toby Richards, London, UK

15:00-15:10 How to implement perioperative PBM—North American perspective
Susan M. Goobie, Boston, MA, USA

15:10-15:30 Discussion

15:30-16:00 Break

16:00-16:08 Change of red cell transfusion use and distribution in a general hospital (2008‒2011)
José Antonio García-Erce, Huesca, Spain

16:08-16:16 First steps in the implementation of a patient blood management programme in Norway
Aurora Espinosa, Oslo, Norway

16:16-16:24 Blood transfusion post elective arthroplasty―a quality improvement programme
Georgina Duignan, Letterkenny, Ireland

16:24-16:32 Implementation of transfusion guidelines and a blood sharing agreement improves red cell utilisation
Natalie Sabine, Dublin, Ireland

16:32-16:40 Modernisation of the maximal surgical blood order schedule
Christopher A. Tormey, New Haven, CT, USA

16:40-16:48 Perioperative blood transfusion is associated with postoperative complications after intracorporeal robotic assisted radical cystectomy
Wei Shen Tan, London, UK

16:48-16:54 Relationship between red blood cell transfusion and outcomes in children undergoing non-cardiac surgery: the dose makes the poison
Susan M. Goobie, Boston, MA, USA

16:54-17:15 Discussion and poster awards

16:00-16:08 Total haemoglobin mass is an important determinant of preoperative exercise capacity measured by cardiopulmonary exercise testing in patients awaiting major surgery
James M. Otto, London, UK

16:08-16:16 Screening data from the PREVENTT trial: a snapshot of preoperative anaemia in the UK
Ben Clevenger, London, UK

16:16-16:24 Analysis of the prevalence and causes of low preoperative haemoglobin levels in a large multicentre cohort of patients undergoing major non-cardiac surgery
José Antonio García-Erce, Huesca, Spain

16:24-16:32 The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomised controlled trial
Bernd Froessler, Adelaide, SA, Australia

16:32-16:40 A cost analysis of intravenous iron administration for treating sub-acute anaemia at a hospital emergency department
Manuel Quintana Díaz, Madrid, Spain

16:40-16:48Development of a predictive model for postoperative bleeding in children undergoing cardiac surgery
Étienne Metallo, Brussels, Belgium

16:48-16:54 Haemostatic function of platelets stored in platelet additive solution C compared with platelets stored in plasma
Fabienne M. A. van Hout, Leiden, The Netherlands

16:54-17:15 Discussion and poster awards


17:30-18:00 NATA General Assembly

Friday, April 15, 2016

MORNING

8:45-9:00 European Transfusion Practice and Outcome Study (ETPOS): a multi-central evaluation of standard of transfusion care and clinical outcome for elective surgical patients
Jens Meier, Linz, Austria

9:00-9:15 DIC interventions in 2016—what have we learnt?
Marcel Levi, Amsterdam, The Netherlands

9:15-9:30 Tranexamic acid as a global haemostatic drug? Lessons from over 300 RCTs
Beverley J. Hunt, London, UK

9:30-9:45 New insights into the use of tranexamic acid in children: from pharmacokinetics to pharmacodynamics
David Faraoni, Boston, MA, USA

9:45-10:00 Update on pathogen inactivation—what about function?
Helen V. New, London, UK

10:00-10:30 Discussion

10:30-11:00 Break

11:00-11:15 Transfusion-related acute lung injury in perioperative and intensive care settings
Alexander Vlaar, Amsterdam, The Netherlands

11:15-11:30 RBC metabolomics—pathways to new understanding
Pär I. Johansson, Copenhagen, Denmark

11:30-11:45 Transfusion thresholds—2016 Cochrane review
Jeffrey L. Carson, New Brunswick, NJ, USA

11:45-12:00 Anaemia in children: impact and prevention
Susan M. Goobie, Boston, MA, USA

12:00-12:30 Discussion

11:00-11:30 Management of anaemia and haematinic deficiencies in pregnancy and in the postpartum period
Manuel Muñoz, Málaga, Spain

11:30-12:00 Prevention and treatment of postpartum haemorrhage
Beverley J. Hunt, London, UK

12:00-12:30 Discussion

Friday, April 15, 2016

AFTERNOON

14:00-14:15 NOACs & haemorrhage—what we have learnt from registries?
David Faraoni, Boston, MA, USA

14:15-14:30 NOACs & antidotes—how to manage bleeding in 2016?
Marcel Levi, Amsterdam, The Netherlands

14:30-14:45 Venous thromboembolism—risk factors in the current standard of care
Charles-Marc Samama, Paris, France

14:45-15:00 Anaemia and thrombosis
Juan V. Llau, Valencia, Spain

15:00-15:30 Discussion

14:00-14:15 Platelet count and outcome
Rainer Moog, Cottbus, Germany

14:15-14:30 Prophylactic platelet transfusions in patients with haematological malignancies—lessons from the TOPPS trial
Lise J. Estcourt, Oxford, UK

14:30-14:45 What about paediatrics & neonates?
Helen V. New, London, UK

14:45-15:00 Alternatives to prophylactic platelet transfusions
Lise J. Estcourt, Oxford, UK

15:00-15:30 Discussion

15:30-16:00 Break

16:00-16:15 Advanced Bleeding Care in Trauma (ABC-T) guidelines
Jacques Duranteau, Paris, France

16:15-16:30 National Institute for Health and Care Excellence (NICE) trauma guideline
Simon Hughes, Southampton, UK

16:30-16:45 Targeted Action Curing Trauma Induced Coagulopathy (TACTIC) programme
Pär I. Johansson, Copenhagen, Denmark

16:45-17:00 British Committee for Standards in Haematology practical guideline for the management of major haemorrhage
Beverley J. Hunt, London, UK

17:00-17:25 Discussion


17:25-17:30 Concluding comments
Jean-François Hardy, Montreal, QC, Canada